Addex Therapeutics

$10.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.37%) Today
-$0.25 (-2.34%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADXN and other stocks, options, and ETFs commission-free!

About ADXN

Addex Therapeutics Ltd American Depositary Shares, also called Addex Therapeutics, is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland. The listed name for ADXN is Addex Therapeutics Ltd American Depositary Shares.

CEO
Timothy Dyer
Employees
23
Headquarters
Geneva, Geneve (Geneva)
Founded
2002
Market Cap
70.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
63.04K
High Today
$10.85
Low Today
$10.40
Open Price
$10.59
Volume
11.06K
52 Week High
$37.52
52 Week Low
$6.19

Collections

ADXN Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 17, Pre-Market

You May Also Like

PPBI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure